Eurand (Milan, Italy) Reports First Half 2007 Key Achievements and Financial Results

AMSTERDAM, Netherlands, Aug. 3, 2007 (PRIME NEWSWIRE) -- Eurand N.V. (NasdaqGM:EURX - News), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, today announced financial results for the six months ended June 30, 2007. These were the first financial results released since Eurand's initial public offering on May 16, 2007.